Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non - Alcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02459496
What this trial is testing

Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus

Who this might be right for
Type 2 DiabetesNAFLDObesity+2 more
German Institute of Human Nutrition 200
Post-approval studies (Phase 4)UnknownNCT06256289
What this trial is testing

Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary SyndromeNon-Alcoholic Fatty Liver Disease
Ping Li,MD 50
Early research (Phase 1)WithdrawnNCT04395950
What this trial is testing

Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism

Who this might be right for
NASH (Nonalcoholic Steatohepatitis)NAFLD (Nonalcoholic Fatty Liver Disease)
Columbia University
Testing effectiveness (Phase 2)Study completedNCT03863574
What this trial is testing

Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Zydus Therapeutics Inc. 16
Not applicableNot Yet RecruitingNCT07640880
What this trial is testing

Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV

Who this might be right for
MASLDHIV (Human Immunodeficiency Virus)
Yinzhong Shen 120
Testing effectiveness (Phase 2)Study completedNCT03987074
What this trial is testing

Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 109
Not applicableStudy completedNCT01579162
What this trial is testing

Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation

Who this might be right for
Hepatitis C, ChronicNon-Alcoholic Fatty Liver Disease
HepQuant, LLC 48
Not applicableStudy completedNCT05051527
What this trial is testing

Study to Evaluate the Effectiveness of Legalon®

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Mylan Inc. 362
Not applicableStudy completedNCT03233178
What this trial is testing

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)Fatty LiverNAFLD
LMC Diabetes & Endocrinology Ltd. 4,000
Not applicableUnknownNCT06341790
What this trial is testing

Effect of Consumption of Millet Diet in Patients With NAFLD

Who this might be right for
NAFLD
Institute of Liver and Biliary Sciences, India 60
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Not applicableStudy completedNCT01680640
What this trial is testing

Investigation of Synbiotic Treatment in NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University Hospital Southampton NHS Foundation Trust 104
Not applicableUnknownNCT03254563
What this trial is testing

Copeptin and Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
University of Colorado, Denver 60
Not applicableStudy completedNCT05807204
What this trial is testing

Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal Obesity

Who this might be right for
Visceral ObesityNon-Alcoholic Fatty Liver Disease
Fundació Eurecat 20
Post-approval studies (Phase 4)Study completedNCT05616442
What this trial is testing

Ketotifen in Non-Alcoholic Fatty Liver Disease Patients

Who this might be right for
Hepatic Disease
Tanta University 60
Not applicableUnknownNCT00928473
What this trial is testing

The Danish Childhood Obesity Biobank

Who this might be right for
ObesityMetabolic DiseaseNAFLD, Non-alcoholic Fatty Liver Disease+1 more
Zealand University Hospital 5,000
Not applicableStudy completedNCT07297225
What this trial is testing

Metabolic Dysfunction-Associated Fatty Liver Disease Impairs Intraoperative Indocyanine Green Fluorescence Cholangiography Quality: Development and Validation of a Predictive Model

Who this might be right for
MAFLDCholecystitisGallbladder Polyps+1 more
Zhujiang Hospital 150
Not applicableStudy completedNCT04161703
What this trial is testing

Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
Cairo University 50
Testing effectiveness (Phase 2)Study completedNCT02854605
What this trial is testing

Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences 140
Not applicableLooking for participantsNCT05335603
What this trial is testing

An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis

Who this might be right for
Chronic Liver Disease
University of Copenhagen 335
Next Page